Cargando…

Selection of Biologics for Type 2–High Asthma

Detalles Bibliográficos
Autor principal: Yilmaz, Insu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775871/
https://www.ncbi.nlm.nih.gov/pubmed/31106563
http://dx.doi.org/10.1164/rccm.201904-0763LE
_version_ 1783456338753355776
author Yilmaz, Insu
author_facet Yilmaz, Insu
author_sort Yilmaz, Insu
collection PubMed
description
format Online
Article
Text
id pubmed-6775871
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-67758712019-10-04 Selection of Biologics for Type 2–High Asthma Yilmaz, Insu Am J Respir Crit Care Med Correspondence American Thoracic Society 2019-09-15 2019-09-15 /pmc/articles/PMC6775871/ /pubmed/31106563 http://dx.doi.org/10.1164/rccm.201904-0763LE Text en Copyright © 2019 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Yilmaz, Insu
Selection of Biologics for Type 2–High Asthma
title Selection of Biologics for Type 2–High Asthma
title_full Selection of Biologics for Type 2–High Asthma
title_fullStr Selection of Biologics for Type 2–High Asthma
title_full_unstemmed Selection of Biologics for Type 2–High Asthma
title_short Selection of Biologics for Type 2–High Asthma
title_sort selection of biologics for type 2–high asthma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775871/
https://www.ncbi.nlm.nih.gov/pubmed/31106563
http://dx.doi.org/10.1164/rccm.201904-0763LE
work_keys_str_mv AT yilmazinsu selectionofbiologicsfortype2highasthma